Shahram Rabbani
Research Center for Advanced Technologies in Cardiovascular Medicine, Tehran Heart Center, Tehran University of Medical Sciences,Tehran,Iran.
[ 1 ] - Simultaneous delivery of Wharton’s jelly mesenchymal stem cells and insulin-like growth factor-1 in acute myocardial infarction
Wharton’s jelly mesenchymal stem cells (HWJMSCs) hold promise for myocardial regeneration, but optimal treatment regimen (preferably with a growth factor) is required to maximize functional benefits. The aim of this study was to explore the cardioprotective and angiogenesis effects of HWJMSCs combined with insulin-like growth factor-1 (IGF-1) in the treatment of acute myocardial infarction. Th...
[ 2 ] - Simultaneous delivery of Wharton’s jelly mesenchymal stem cells and insulin-like growth factor-1 in acute myocardial infarction
Wharton’s jelly mesenchymal stem cells (HWJMSCs) hold promise for myocardial regeneration, but optimal treatment regimen (preferably with a growth factor) is required to maximize functional benefits. The aim of this study was to explore the cardioprotective and angiogenesis effects of HWJMSCs combined with insulin-like growth factor-1 (IGF-1) in the treatment of acute myocardial infarction. Th...
[ 3 ] - کاربرد نانوذرات در بیماریهای قلبی ـ عروقی
Cardiovascular diseases remain the leading cause of death worldwide. In spite of major efforts in medical and surgical interventions, deaths from cardiovascular diseases remain unacceptably high, warranting novel strategies for more effective treatments. To improve cardiovascular diseases therapy, novel drug delivery systems such as nanoparticles, which can control drug biodistribution and spec...
نویسندگان همکار